Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assunta Senatore

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Cell Biology|December 27, 2013
Synaptic dysfunction in prion diseases: a trafficking problem?Assunta Senatore, Elena Restelli, Roberto Chiesa
BMC Biology|May 4, 2017
The biological function of the cellular prion protein: an updateMarie-Angela Wulf, Assunta Senatore, Adriano Aguzzi
Advances in Therapy|December 22, 2021
The Epidemiology of Persons Living with Fontan in 2020 and Projections for 2030: Development of an Epidemiology Model Providing Multinational EstimatesLeandra Plappert, Susan Edwards, Assunta Senatore, et al.
The Biochemical Journal|December 17, 2013
The inhibition of functional expression of calcium channels by prion protein demonstrates competition with α2δ for GPI-anchoring pathwaysAnita Alvarez-Laviada, Ivan Kadurin, Assunta Senatore, et al.
Communications Biology|June 21, 2022
Author Correction: Brain aging is faithfully modelled in organotypic brain slices and accelerated by prionsYingjun Liu, Assunta Senatore, Silvia Sorce, et al.
Communications Biology|June 8, 2022
Brain aging is faithfully modelled in organotypic brain slices and accelerated by prionsYingjun Liu, Assunta Senatore, Silvia Sorce, et al.
Plos One|September 30, 2016
Neurotoxic Antibodies against the Prion Protein Do Not Trigger Prion ReplicationKarl Frontzek, Manuela Pfammatter, Silvia Sorce, et al.
Advances in Therapy|May 19, 2025
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUSNick H Kim, Kelly M Chin, Vallerie V McLaughlin, et al.
Advances in Therapy|September 24, 2024
Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS StudiesKelly M Chin, Richard Channick, Nick H Kim, et al.
Brain Pathology (Zurich, Switzerland)|February 18, 2022
Glial activation in prion diseases is selectively triggered by neuronal PrP<sup>Sc</sup>Asvin K K Lakkaraju, Silvia Sorce, Assunta Senatore, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Cell Biology|December 27, 2013
Synaptic dysfunction in prion diseases: a trafficking problem?Assunta Senatore, Elena Restelli, Roberto Chiesa
BMC Biology|May 4, 2017
The biological function of the cellular prion protein: an updateMarie-Angela Wulf, Assunta Senatore, Adriano Aguzzi
Advances in Therapy|December 22, 2021
The Epidemiology of Persons Living with Fontan in 2020 and Projections for 2030: Development of an Epidemiology Model Providing Multinational EstimatesLeandra Plappert, Susan Edwards, Assunta Senatore, et al.
The Biochemical Journal|December 17, 2013
The inhibition of functional expression of calcium channels by prion protein demonstrates competition with α2δ for GPI-anchoring pathwaysAnita Alvarez-Laviada, Ivan Kadurin, Assunta Senatore, et al.
Communications Biology|June 21, 2022
Author Correction: Brain aging is faithfully modelled in organotypic brain slices and accelerated by prionsYingjun Liu, Assunta Senatore, Silvia Sorce, et al.
Communications Biology|June 8, 2022
Brain aging is faithfully modelled in organotypic brain slices and accelerated by prionsYingjun Liu, Assunta Senatore, Silvia Sorce, et al.
Plos One|September 30, 2016
Neurotoxic Antibodies against the Prion Protein Do Not Trigger Prion ReplicationKarl Frontzek, Manuela Pfammatter, Silvia Sorce, et al.
Advances in Therapy|May 19, 2025
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUSNick H Kim, Kelly M Chin, Vallerie V McLaughlin, et al.
Advances in Therapy|September 24, 2024
Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS StudiesKelly M Chin, Richard Channick, Nick H Kim, et al.
Brain Pathology (Zurich, Switzerland)|February 18, 2022
Glial activation in prion diseases is selectively triggered by neuronal PrP<sup>Sc</sup>Asvin K K Lakkaraju, Silvia Sorce, Assunta Senatore, et al.
Pageof 3